Climb Bio Inc Analysis
| Analyst Ratings |
|
Average Target Price
|
|
|
Average Rating
|
|
|
# Strong Buys
|
|
|
# Buys
|
|
|
# Holds
|
|
|
# Sells
|
|
|
# Strong Sells
|
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2024-09-30
|
0.00
|
-0.13
|
0.00
|
0.00%
|
|
2024-06-30
|
0.00
|
-1.81
|
0.00
|
0.00%
|
|
2024-03-31
|
0.00
|
-0.06
|
0.00
|
0.00%
|
|
2023-12-31
|
0.00
|
-0.13
|
0.00
|
0.00%
|
|
2023-09-30
|
0.00
|
-0.15
|
0.00
|
0.00%
|
|
2023-06-30
|
0.00
|
-0.19
|
0.00
|
0.00%
|
|
2023-03-31
|
0.00
|
-0.84
|
0.00
|
0.00%
|
|
2022-12-31
|
0.00
|
-0.29
|
0.00
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2024-09-30
|
-2.00
|
|
2023-12-31
|
-1.31
|
|
2022-12-31
|
-1.71
|
|
2021-12-31
|
-1.23
|